An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.
Morrow PK; Murthy RK; Ensor JD; Gordon GS; Margolin KA; Elias AD; Urba WJ; Weng DE; Rugo HS; Hortobagyi GN; Cancer, 2012, vol. 118, issue 17, p 4098, ISSN 10970142. ISBN 10970142.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef